Skip to content

Ceres Pharma

Active
Public limited companyfounded 2015active for 10 yearsKortrijksesteenweg 1091, 9051 Gent, Belgium23 active companies are registered at this addressKBO/BCE: BE 0641.953.324
Summary

The computed 12-month bankruptcy probability of Ceres Pharma is 1.9% (moderate). The 2025 annual accounts show negative equity (-€1.6m) and a net result of -€14.4m. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
Ceres PharmaActiveChecked score 53/100
Risk analysis ReportCompare

Articles of association

Other provisionsOther rules from the articles that fall under none of the themes above.
Other provision: “Verantwoordelijkheid van het bestuursorgaan” (deed in Dutch)
Other provision: “Verantwoordelijkheid van de commissaris” (deed in Dutch)

Read from the deeds: 2 provisions, deed of 27-05-2024

We would like to set cookies. That happens only with your consent. What we measure